HCT Core Topics Connection: Chimeric Antigen Receptor (CAR) T-cell Therapies


Back to Package

This module will summarize the mechanism of action and manufacturing process of CAR T-cells, evaluate data supporting the use of the FDA-approved CART T-cell products, and discuss the presentation and management of CAR T-cell toxicities. 

Presented by:

Katie S. Gatwood, PharmD, BCOP – Vanderbilt University Medical Center

May T. Aziz, PharmD, BCOP – Virginia Commonwealth University Health System


Key:

Complete
Failed
Available
Locked
Module Recording
Open to view video.
Open to view video. This module will focus on Chimeric Antigen Receptor (CAR) T-cell Therapies. It is presented by Katie S. Gatwood, PharmD, BCOP and May T. Aziz, PharmD, BCOP.
You must register to access.
Slides
Open to download resource.
Open to download resource.
You must register to access.
Module Quiz
10 Questions  |  4 attempts  |  8/10 points to pass
10 Questions  |  4 attempts  |  8/10 points to pass
You must register to access.
Evaluation
6 Questions
6 Questions
You must register to access.
Certificate of Completion
No credits available  |  Certificate available
No credits available  |  Certificate available
You must register to access.